Pricing Log in Create free account
Friday 6 November 2026 Export TGTX’s income statement to Excel — free account

TG Therapeutics, Inc.

TGTX Healthcare Biotechnology

TG Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $616.3 million, up 87.3% from fiscal 2024.

Revenue
+70.3%
EPS
−73.7%
Free cash flow
+427.1%
Total debt
+204.2%

Quarter to June 2026, against a year earlier

59.37 1.39 +2.40%
Market cap
$8.9B
P/E
19.1×
Fwd P/E
62.4×
Dividend yield
—
F-score
5/9
Altman Z
6.29
Beneish M
0.80
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

TG Therapeutics, Inc. (TGTX) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, TG Therapeutics, Inc. (TGTX) trades at a P/S ratio of 10.3×. Over the past ten years it has ranged from 5.0× (October 2023) to 43,044× (December 2020); the current reading is higher than 17% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 7.0× (47.49%)
FY2024 13.3× 28.42%
FY2023 10.4× (98.16%)
FY2022 563× 49.78%
FY2021 376× (99.05%)
FY2020 39,472× 511.65%
FY2019 6,453× 217.02%
FY2018 2,036× (43.03%)
FY2017 3,573× 148.87%
FY2016 1,436× (59.82%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 9.7× 42.19%
Mar 2026 6.9× (1.86%)
Dec 2025 7.0× (29.33%)
Sep 2025 9.9× (15.07%)
42 more quarters

Against its own ten years

Low 5.0× High 43,044×
Ten-year median 2,055×
Current reading's percentile 18

P/S ratio against peers

Company P/S ratio
CAI Caris Life Sciences,�Inc. compare 7.1×
MDGL Madrigal Pharmaceuticals, Inc. compare 8.2×
TGTX TG Therapeutics, Inc. 10.3×
TWST Twist Bioscience Corporation compare 17.6×
KRYS Krystal Biotech, Inc. compare 18.9×
PTGX Protagonist Therapeutics, Inc. compare 31.7×
IBRX ImmunityBio, Inc. compare 51.0×
CYTK Cytokinetics, Incorporated compare 64.4×
SYRE Spyre Therapeutics, Inc. compare 8,160×
Biotechnology industry median 9.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on TGTX